未登录 分享 收藏
分享 收藏
分享 收藏
The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trial SHARE研究——头颈癌幸存者生存状况:评估加拿大安大略省的患者护理和随访依从性:一项随机对照试验的研究方案 Tran, Billy; Dzioba, Agnieszka; Baker, Jennifer; Mutsaers, Adam; Nichols, Anthony C.; Mendez, Adrian; Goodman, Chris D.; Palma, David A.; Winquist, Eric; Irwin, Jennifer D.; Fung, Kevin; Stewart, Paul; Lang, Pencilla; Correa, Rohann J. M.; Kuruvilla, Sara; Mitchell, Sylvia; Phillips, Timothy; MacNeil, S. Danielle 分享 收藏
分享 收藏
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma 转移性乳头状肾细胞癌一线治疗的临床结局真实世界评估 De Vries-Brilland, Manon; Hamilou, Zineb; Ghosh, Sunita; Heng, Daniel Y. C.; Wood, Lori A.; Basappa, Naveen S.; Kollmannsberger, Christian K.; Graham, Jeffrey; Bhindi, Bimal; Finelli, Antonio; Bjarnason, Georg A.; Bosse, Dominick; Pouliot, Frederic; Castonguay, Vincent; Breau, Rodney H.; Saleh, Ramy R.; Winquist, Eric; Lalani, Aly-Khan A.; Soulieres, Denis 分享 收藏
Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial Zayed, Sondos; Lang, Pencilla; Read, Nancy; Correa, Rohann J. M.; Mutsaers, Adam; Goodman, Christopher D.; D'Angelo, Krista; Kieraszewicz, Kelsey; Vanwynsberghe, Danielle; Kingsbury-Paul, Alika; Crewdson, Kathlin; Neeb, Jennifer; Carreau, Caitlin; Winquist, Eric; Kuruvilla, Sara; Stewart, Paul; Moulin, Dwight E.; Warner, Andrew; Palma, David A. 分享 收藏
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management (Nov, 10.1007/s12022-024-09836-x, 2024) Mete, Ozgur; Boucher, Andree; Schrader, Kasmintan A.; Abdel-Rahman, Omar; Bahig, Houda; Ho, Cheryl; Hasan, Olfat Kamel; Lemieux, Bernard; Winquist, Eric; Wong, Ralph; Wu, Jonn; Chau, Nicole; Ezzat, Shereen 分享 收藏
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma III期随机CLEAR试验的生物标志物分析:lenvatinib联合pembrolizumab与sunitinib治疗晚期肾细胞癌的比较 Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Gruenwald, V.; George, S.; Markensohn, J.; Burgents, J. E.; Cristescu, R.; Sachdev, P.; Narita, Y.; Huang, J.; Zhao, Z.; Okpara, C. E.; Minoshima, Y.; Choueiri, T. K. 分享 收藏
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma Ezzat, Shereen; Pasternak, Jesse D.; Rajaraman, Murali; Abdel-Rahman, Omar; Boucher, Andree; Chau, Nicole G.; Chen, Shirley; Gill, Sabrina; Hyrcza, Martin D.; Lamond, Nathan; Massicotte, Marie-Helene; Winquist, Eric; Mete, Ozgur 分享 收藏
分享 收藏
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study 在3期CLEAR研究的最终预设生存分析中,晚期肾细胞癌患者对Lenvatinib联合Pembrolizumab的反应特征 Motzer, Robert J.; Choueiri, Toni K.; Hutson, Thomas; Rha, Sun Young; Puente, Javier; Lalani, Aly-Khan A.; Winquist, Eric; Eto, Masatoshi; Basappa, Naveen S.; Tannir, Nizar M.; Vaishampayan, Ulka; Bjarnason, Georg A.; Oudard, Stephane; Gruenwald, Viktor; Burgents, Joseph; Xie, Ran; McKenzie, Jodi; Powles, Thomas 分享 收藏
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies 接受一线全身治疗的有或没有肉瘤样特征的转移性肾细胞癌患者临床结局的真实世界评估 Sawaya, Ghady Bou-Nehme; Dragomir, Alice; Wood, Lori A.; Kollmannsberger, Christian; Basappa, Naveen S.; Kapoor, Anil; Soulieres, Denis; Finelli, Antonio; Heng, Daniel Y. C.; Castonguay, Vincent; Canil, Christina; Winquist, Eric; Graham, Jeffrey; Bjarnason, Georg A.; Bhindi, Bimal; Lalani, Aly-Khan; Pouliot, Frederic; Breau, Rodney H.; Saleh, Ramy; Tanguay, Simon 分享 收藏
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium 畸胎瘤对转移性非精原细胞性生殖细胞癌患者生存概率的影响: IGCCCG更新联盟的结果 Buhrer, Emanuel; D'Haese, David; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A.; De Giorgi, Ugo; Cafferty, Fay H.; Hansen, Aaron R.; Tandstad, Torgrim; Huddart, Robert A.; Necchi, Andrea; Sweeney, Christopher J.; Garcia-Del-Muro, Xavier; Heng, Daniel Y. C.; Lorch, Anja; Chovanec, Michal; Winquist, Eric; Grimison, Peter; Feldman, Darren R.; Terbuch, Angelika; Hentrich, Marcus; Bokemeyer, Carsten; Negaard, Helene; Fankhauser, Christian; Shamash, Jonathan; Vaughn, David J.; Sternberg, Cora N.; Heidenreich, Axel; Collette, Laurence; Gillessen, Silke; Beyer, Jorg 分享 收藏
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma 辅助Pembrolizumab治疗肾细胞癌的总生存率 Choueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Symeonides, S. N.; Hajek, J.; Chang, Y-H; Lee, J-L; Sarwar, N.; Haas, N. B.; Gurney, H.; Sawrycki, P.; Mahave, M.; Gross-Goupil, M.; Zhang, T.; Burke, J. M.; Doshi, G.; Melichar, B.; Kopyltsov, E.; Alva, A.; Oudard, S.; Topart, D.; Hammers, H.; Kitamura, H.; McDermott, D. F.; Silva, A.; Winquist, E.; Cornell, J.; Elfiky, A.; Burgents, J. E.; Perini, R. F.; Powles, T. 分享 收藏
Understanding and overcoming innate and acquired resistance to type I and II RAF inhibitors in anaplastic thyroid cancer using translational functional genomics Zeng, Peter; Meens, Jalna; Barrett, John; Cecchini, Matthew J.; Ryan, Sarah B.; Pan, Nachuan; Karimi, Amir; Jarycki, Laura; Dawson, Alice E.; Shaikh, Mushfiq; Palma, David; Winquist, Eric; Boutros, Paul C.; Ailles, Laurie; Nichols, Anthony C. 分享 收藏
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma 间变性甲状腺癌的基因组和进化景观 Zeng, Peter Y. F.; Prokopec, Stephenie D.; Lai, Stephen Y.; Pinto, Nicole; Chan-Seng-Yue, Michelle A.; Clifton-Bligh, Roderick; Williams, Michelle D.; Howlett, Christopher J.; Plantinga, Paul; Cecchini, Matthew J.; Lam, Alfred K.; Siddiqui, Iram; Wang, Jianxin; Sun, Ren X.; Watson, John D.; Korah, Reju; Carling, Tobias; Agrawal, Nishant; Cipriani, Nicole; Ball, Douglas; Nelkin, Barry; Rooper, Lisa M.; Bishop, Justin A.; Garnis, Cathie; Berean, Ken; Nicolson, Norman G.; Weinberger, Paul; Henderson, Ying C.; Lalansingh, Christopher M.; Tian, Mao; Yamaguchi, Takafumi N.; Livingstone, Julie; Salcedo, Adriana; Patel, Krupal; Vizeacoumar, Frederick; Datti, Alessandro; Xi, Liu; Nikiforov, Yuri E.; Smallridge, Robert; Copland, John A.; Marlow, Laura A.; Hyrcza, Martin D.; Delbridge, Leigh; Sidhu, Stan; Sywak, Mark; Robinson, Bruce; Fung, Kevin; Ghasemi, Farhad; Kwan, Keith; MacNeil, S. Danielle; Mendez, Adrian; Palma, David A.; Khan, Mohammed I.; Shaikh, Mushfiq; Ruicci, Kara M.; Wehrli, Bret; Winquist, Eric; Yoo, John; Mymryk, Joe S.; Rocco, James W.; Wheeler, David; Scherer, Steve; Giordano, Thomas J.; Barrett, John W.; Faquin, William C.; Gill, Anthony J.; Clayman, Gary; Boutros, Paul C.; Nichols, Anthony C. 分享 收藏
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms (vol 13, 1223282, 2023) Grunwald, Viktor; Powles, Thomas; Eto, Masatoshi; Kopyltsov, Evgeny; Rha, Sun Young; Porta, Camillo; Motzer, Robert; Hutson, Thomas E.; Mendez-Vidal, Maria Jose; Hong, Sung-Hoo; Winquist, Eric; Goh, Jeffrey C.; Maroto, Pablo; Buchler, Tomas; Takagi, Toshio; Burgents, Joseph E.; Perini, Rodolfo; He, Cixin; Okpara, Chinyere E.; McKenzie, Jodi; Choueiri, Toni K. 分享 收藏
分享 收藏